TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015. November 23, 2005
TCL Archive In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official June 27, 1980
